Category Archives: Defective Drugs

FDA Recall Heart Medication Digitek, Bertek, UDL by Actavis, Mylan

NEWS May 5, 2008
Heart Medications Recalled – Patients with Renal Failure Need to Take Heed
Heart medications are an essential part of life for millions of people, particularly those who have dealt with heart failure and/or those who suffer from irregular heartbeats. The demand for these medications is at an all-time high, and drug […]

Bayer Drug Trasylol injection on 60 minutes reports kidney failure, Death

NEWS: February 19, 2008 Bayer Drug Trasylol.
60 Minutes does show on Bayer Drug Trasylol.
A renowned medical researcher estimates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago. In a scathing documentary the television show 60 Minutes tells of one researcher’s findings on […]

FDA Warning Botox Cosmetics, Myobloc Respiratory Compromise & Death

February 8, 2008
The FDA issued an early communication about an ongoing safety review regarding Botox and Botox Cosmetic.
FDA has received reports of systemic adverse reactions including respiratory compromise and death following the use of botulinum toxins types A and B for both FDA-approved and unapproved uses. The reactions reported are suggestive of botulism, which occurs […]

FDA Alert for Colchicine Side Effects & Deaths

February 6, 2008
The FDA has stated it decision to take enforcement action against any company marketing injectable Colchicine that is unapproved. Anextremely toxic drug, Colchicine is used to treat gout and can very easily be given in excessive doses, resulting in serious side effects, low blood counts, organ failure, cardiac events and even death. 
The FDA […]

Avandia News Alert: Clinical Trials Halted due to Deaths.

February 6, 2008
The government announced Wednesday that the 10,000 patient ACCORD clinical trial involving diabetes treatment has been halted 18 months early due to increased risk of patients death. The trial was stopped after the Data Safety and Monitoring Board found that the rigorous treatment increased the patients’ risk of death by 25%.
 
The results bring […]

FDA warns Epilepsy Antiepileptic Drugs increase suicidal behavior

January 31, 2008 FDA study shows some antiepileptic drugs may increase the risk of suicidal behavior:
The drugs listed below used to treat epilepsy and other disorders identified to increase the risk for suicidal behavior.
The FDA looked at 11 drugs:
Carbamazepine (Carbatrol, Equetro, Tegretol, Tegretol XR)
Felbamate (Felbatol)
Gabapentin (Neurontin)
Lamotrigine (Lamictal)
Levetiracetam (Keppra)
Oxcarbazepine (Trileptal)
Pregabalin (Lyrica)
Tiagabine (Gabitril)
Topiramate (Topamax)
Valproate (Depakote, Depakote ER, […]

Vytorin, Zetia Side Effects Under FDA Scrutiny

On Tuesday, January 22 2008 Merck/Schering-Plough announced the pulling of all TV advertisements for the drugs Zetia and Vytorin. Zetia alone is a Merck/Scherin anti-cholesterol drug and Vytorin is a drug that contains both Zetia and Zocor(simvastation).
At least one of the ads boasted that Zetia was far greater than less expensive statin drugs for lowering […]

Vioxx settlement Merck agrees to pay $4.85 bln

NEW YORK (Reuters) - Merck & Co has agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes in thousands of users, the drugmaker said on Friday.
The agreement covers lawsuits filed against the company in U.S. courts, resolving a major legal battle that has dogged the drugmaker since […]

Birth Control Pill linked to increased Risk of Heart Attack or Stroke

ORLANDO, Florida (Reuters) - A European study released on Tuesday has raised new concerns about the safety of women’s long-term use of the birth control pill, suggesting increased risk of heart attack or stroke.
Women who had used oral contraceptives were more likely than those who did not take the pill to have a buildup of […]

Trasylol Side Effects cause FDA Suspension Request

The FDA announced that, at the agency’s request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol (aprotinin injection), a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death. FDA requested the suspension in the interest of […]